¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ ½ÉÆ÷Áö¾ö : 2019-06-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ ½ÉÆ÷Áö¾ö : 2019-06-22
±³À°ÀÏÀÚ : 2019-06-22
±³À°Àå¼Ò : ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101, 102È£  
±³À°ÁÖÁ¦ : 2019³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ 
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ±Ù¿¬±¸È¸  
´ã´çÀÚ : Çѹμö
¿¬¶ôó : 031-981-2764  
À̸ÞÀÏ : daonics@naver.com      
±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : °­¿øµµ
±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í µî·Ïºñ ±¸ºÐ »çÀüµî·Ï ÇöÀåµî·Ï ¿¬È¸ºñ Á¤È¸¿ø(Àü¹®ÀÇ) ¹«·áµî·Ï ¹«·áµî·Ï 50,000¿ø ºñȸ¿ø(Àü¹®ÀÇ) 30,000¿ø 40,000¿ø ¾øÀ½ ½ÅÀÔȸ¿ø(Àü¹®ÀÇ) ¾øÀ½ ¾øÀ½ 50,000¿ø Àü°øÀÇ ¹× ±âŸÀÇ·áÁø 20,000¿ø 30,000¿ø ¾øÀ½      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 09:00~09:25 Clinical applications of neuromuscular monitoring  ¼­Á¤È­(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 09:25~09:50 Current evidence-based recommendations for monitoring and reversal  ±èÁø¼±(°­¸ª¾Æ»êº´¿ø) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 09:50~10:15 Malignant hyperthermia and muscle-related disorder  ±è±Ô³²(ÇѾçÀÇ´ë) 
Åä·Ð 06-22  10:15~10:35 Q & A  () 
È޽Ġ06-22  10:35~10:50 Break  () 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 10:50~11:15 Clinical applications of neuromuscular monitoring  ¾çÈ«¼®(´ëÀü ¼±º´¿ø) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 11:15~11:40 Current evidence-based recommendations for monitoring and reversal  ÀÌ¿øÁø(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 11:45~12:05 Malignant hyperthermia and muscle-related disorder  ÃÖÀç¹®(¿ï»êÀÇ´ë) 
Åä·Ð 06-22  12:05~12:25 Q & A  () 
½Ä»ç 06-22  12:30~13:30 Lunch  () 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 13:30~13:55 Recent literature review; sugammadex: what do we know and what do we still need to know?  Á¤±âÅÂ(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 13:55~14:20 Statistical/methodology: randomization  ÀÎÁØ¿ë(µ¿±¹ÀÇ´ë) 
Åä·Ð 06-22  14:20~14:35 Q & A  () 
È޽Ġ06-22  14:35~14:50 Break  () 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 14:50~15:10 Retrospective analysis of 30-day unplanned readmission after major abdominal surgery with reversal by sugammadex or neostigmine  ¿ÀŹ±Ô(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 15:10~15:30 Effects of magnesium chloride on rocuronium-induced neuromuscular blockade and sugammadex reversal in an isolated rat phrenic nerve-hemidiaphragm preparation  ¼ºÅÂÀ±(°Ç¾çÀÇ´ë) 
±³À°½Ã°£ 06-22 ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Áø¸®°ü 1Ãþ 101È£ 15:30~15:50 Comparison of rocuronium-induced neuromuscular blockade in second trimester pregnant women and non-pregnant women  ÀüÀÎÁ¤(ÇѸ²ÀÇ´ë) 
Åä·Ð 06-22  15:50~16:10 Q & A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ ½ÉÆ÷Áö¾ö : 2019-06-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2019³â Á¦1Â÷ ´ëÇÑÁßȯÀÚÀÇÇÐȸ ´ëÀüÃæûÁöȸ ¿¬¼ö±³À° : 2019-06-22
´ÙÀ½±Û 2019 °¡Ãµ´ë ±æº´¿ø-ÀÎõÁ¤Çü¿Ü°úÀÇ»çȸ ¿¬¼ö °­Á : 2019-06-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 3 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 4 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 5 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 4 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 7 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 4 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 3 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 2 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 5 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 5 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷